Designation: Senior Research Scientist
Department: Molecular Genetics
IRCCS-Istituto Tumori
Country: Italy
Dr. Simona De Summa gained a Master’s Degree in Molecular Biology (University of Parma, Italy) with a thesis regarding the role of clusterin in prostate cancer. Thus, she started to work in IRCCS-Istituto Tumori “Giovanni Paolo II” (Bari-ITALY) where she was first employed as the wet scientist. In the meantime, she terminated a Specialization Course in “Medical Statistics and Genomics”, which introduced her in the fields of statistics and bioinformatics.
Indeed, she started a collaboration with the University of Verona for the improvement of variant calling for Next Generation Sequencing data. She is part of the working group of bioinformaticians of Alliance against Cancer, a network which groups together Italian research institutes. To date, she is involved in many projects focusing on personalized therapies for cancer patients.
Her research interest mainly focuses on bioinformatics and the comprehensive analysis of NGS data in order to obtain even more information regarding immune-microenvironment of tumours.“Medical Statistics and Genomics”.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
